CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 230 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,360,825 | +61.7% | 1,518,107 | +32.0% | 0.04% | +65.4% |
| Q2 2023 | $25,579,691 | +50.6% | 1,149,649 | +46.6% | 0.03% | +44.4% |
| Q1 2023 | $16,985,751 | -29.9% | 784,199 | -34.2% | 0.02% | -33.3% |
| Q4 2022 | $24,216,791 | -41.4% | 1,192,358 | -26.0% | 0.03% | -44.9% |
| Q3 2022 | $41,327,000 | +7.8% | 1,611,824 | +0.0% | 0.05% | +8.9% |
| Q2 2022 | $38,319,000 | +52.1% | 1,611,420 | +44.0% | 0.04% | +87.5% |
| Q1 2022 | $25,194,000 | +223.2% | 1,118,711 | +184.1% | 0.02% | +300.0% |
| Q4 2021 | $7,796,000 | +75.5% | 393,748 | +74.5% | 0.01% | +50.0% |
| Q3 2021 | $4,441,000 | +47.5% | 225,677 | +64.9% | 0.00% | +33.3% |
| Q2 2021 | $3,011,000 | -55.6% | 136,856 | -52.0% | 0.00% | -57.1% |
| Q1 2021 | $6,783,000 | -52.1% | 285,117 | -47.4% | 0.01% | -46.2% |
| Q4 2020 | $14,172,000 | +91.3% | 541,759 | +27.3% | 0.01% | +62.5% |
| Q3 2020 | $7,407,000 | +35.6% | 425,567 | +31.0% | 0.01% | +14.3% |
| Q2 2020 | $5,462,000 | +61.6% | 324,754 | +14.3% | 0.01% | +40.0% |
| Q1 2020 | $3,380,000 | +5.6% | 284,237 | +7.4% | 0.01% | +25.0% |
| Q4 2019 | $3,202,000 | -39.9% | 264,620 | -29.8% | 0.00% | -42.9% |
| Q3 2019 | $5,325,000 | +176.3% | 376,733 | +118.1% | 0.01% | +250.0% |
| Q2 2019 | $1,927,000 | +1238.2% | 172,757 | +1307.7% | 0.00% | – |
| Q1 2019 | $144,000 | -98.0% | 12,272 | -97.7% | 0.00% | -100.0% |
| Q4 2018 | $7,091,000 | +291.1% | 530,783 | +310.5% | 0.01% | +400.0% |
| Q3 2018 | $1,813,000 | +87.1% | 129,290 | +119.4% | 0.00% | +100.0% |
| Q1 2018 | $969,000 | -56.0% | 58,928 | -51.7% | 0.00% | -66.7% |
| Q4 2017 | $2,202,000 | -66.5% | 121,925 | -64.2% | 0.00% | -70.0% |
| Q3 2017 | $6,564,000 | +92.2% | 340,118 | +17.5% | 0.01% | +66.7% |
| Q2 2017 | $3,416,000 | +36.7% | 289,533 | +27.0% | 0.01% | +50.0% |
| Q1 2017 | $2,499,000 | -20.3% | 228,025 | -47.2% | 0.00% | -20.0% |
| Q4 2016 | $3,136,000 | +240.5% | 431,886 | +204.6% | 0.01% | +150.0% |
| Q3 2016 | $921,000 | +55.6% | 141,784 | +30.8% | 0.00% | +100.0% |
| Q2 2016 | $592,000 | +67.7% | 108,433 | +43.6% | 0.00% | 0.0% |
| Q1 2016 | $353,000 | -70.6% | 75,511 | -68.6% | 0.00% | -50.0% |
| Q4 2015 | $1,199,000 | +266.7% | 240,709 | +176.3% | 0.00% | – |
| Q3 2015 | $327,000 | +610.9% | 87,121 | +507.6% | 0.00% | – |
| Q4 2013 | $46,000 | +119.0% | 14,338 | +7.5% | 0.00% | – |
| Q3 2013 | $21,000 | -22.2% | 13,333 | -13.0% | 0.00% | – |
| Q2 2013 | $27,000 | – | 15,333 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
| Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
| Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
| Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
| S&T BANK/PA | 346,306 | $7,033 | 1.30% |
| Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
| Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
| FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
| Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |